PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 161 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,926,000 | -18.1% | 974,439 | 0.0% | 0.05% | -14.8% |
| Q2 2019 | $6,012,000 | +7.8% | 974,439 | -18.9% | 0.05% | +14.9% |
| Q1 2019 | $5,576,000 | -4.9% | 1,201,639 | -14.0% | 0.05% | -11.3% |
| Q4 2018 | $5,866,000 | -35.6% | 1,396,639 | -3.9% | 0.05% | -15.9% |
| Q3 2018 | $9,113,000 | -3.7% | 1,453,456 | +23.5% | 0.06% | -3.1% |
| Q2 2018 | $9,465,000 | +9.2% | 1,177,256 | +1.3% | 0.06% | +6.6% |
| Q1 2018 | $8,670,000 | +20.3% | 1,162,256 | -4.0% | 0.06% | +27.1% |
| Q4 2017 | $7,205,000 | -23.8% | 1,210,856 | -5.8% | 0.05% | -23.8% |
| Q3 2017 | $9,456,000 | +3.4% | 1,284,774 | -4.6% | 0.06% | +3.3% |
| Q2 2017 | $9,142,000 | -22.6% | 1,346,374 | +7.7% | 0.06% | -20.8% |
| Q1 2017 | $11,806,000 | -6.4% | 1,250,674 | -14.3% | 0.08% | -4.9% |
| Q4 2016 | $12,607,000 | +15.2% | 1,459,174 | -15.6% | 0.08% | +12.5% |
| Q3 2016 | $10,940,000 | +35.5% | 1,728,350 | -9.7% | 0.07% | +35.8% |
| Q2 2016 | $8,074,000 | -13.4% | 1,913,350 | -10.5% | 0.05% | -10.2% |
| Q1 2016 | $9,323,000 | -33.4% | 2,138,350 | -6.3% | 0.06% | -29.8% |
| Q4 2015 | $13,990,000 | -17.9% | 2,282,250 | -23.4% | 0.08% | -6.7% |
| Q3 2015 | $17,040,000 | -29.1% | 2,978,950 | -7.5% | 0.09% | -11.8% |
| Q2 2015 | $24,035,000 | +135.3% | 3,221,850 | +88.6% | 0.10% | +161.5% |
| Q1 2015 | $10,213,000 | -19.7% | 1,707,850 | +1.5% | 0.04% | -11.4% |
| Q4 2014 | $12,722,000 | +260.5% | 1,682,850 | +147.5% | 0.04% | +266.7% |
| Q3 2014 | $3,529,000 | – | 680,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|